P

Proxima

AI-driven proximity-based drug discovery platform

Computational Biologist

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • Hold a Master of Science or PhD degree in computational biology, bioinformatics, or a related field.
  • Possess mixed academic and/or industrial experience, preferably in the biotechnology industry.
  • Have a strong background in computational structural or systems biology.
  • Demonstrate strong programming skills in Python, R, and/or other languages.
  • Have experience building reproducible and scalable computational biology workflows.
  • Have experience designing and applying machine learning models.

Responsibilities

  • Develop pilot capabilities and create large-scale data pipelines from the ground up.
  • Collaborate with other teams across Proxima and partnering organizations to achieve project goals by contributing code, analyses, benchmarks, optimizations, and ideas to ongoing research-driven projects.
  • Integrate biological insights into the next generation of artificial intelligence and machine learning models for drug discovery.
  • Validate and interpret computational predictions by working closely with experimentalists.

Desired Qualifications

  • Experience with geometric deep learning, graph neural networks, protein language models, transformers, and representation learning is a plus.
  • Prior exposure to drug discovery problems is preferred.
  • Experience working with cloud-based infrastructure.
  • Agile project management.

About the Company

Proxima

AI-driven proximity-based drug discovery platform

Proxima provides AI-native tools for drug discovery focused on how proteins interact. Its NeoLink system uses cross-linking mass spectrometry to map protein complexes across the proteome, generating 3D interaction data; Neo-1 is an atomistic AI model that unifies de novo molecule design with multimodal structure prediction to tailor small molecules that can form or modulate protein interfaces, enabling molecular glues and PROTACs. Unlike many firms that target single proteins, Proxima combines large-scale structural proteomics with an advanced AI framework to drive proximity-based therapeutics that influence protein interaction networks. Its goal is to become essential infrastructure for next-generation drug discovery and to advance programs into clinical trials, with partnerships with major biopharma and an internal pipeline.

Company size
51-200
Company stage
Seed
Total funding
$80M
Headquarters
New York City, New York
Founded
2019

Recently Posted Jobs

Explore more opportunities at Proxima

See more jobs